GlucoTrack, Inc.

The Company was incorporated on May 18, 2010 under the laws of the State of Delaware. We are a medical device company focused on the development of an implantable continuous blood glucose monitor (“CBGM”) for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes (the “Glucotrack CBGM”).

Current securities

1. Entry into a Material Definitive Agreement · Regulation FD DisclosureSep 24, 2026
2. 425 filingSep 23, 2026
3. Regulation FD DisclosureSep 23, 2026
4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 18, 2026
5. S-1 filingSep 18, 2026